Mutant PIK3CA promotes cell growth and invasion of human cancer cells

Cancer Cell

Volumn 7, Issue 6, 2005, Pages 561-573

  Samuels, Yardena ^a   Diaz Jr , Luis A ^a   Schmidt Kittler, Oleg ^a   Cummins, Jordan M ^a   DeLong, Laura ^a   Cheong, Ian ^a   Rago, Carlo ^a   Huso, David L ^a   Lengauer, Christoph ^a   Kinzler, Kenneth W ^a   Vogelstein, Bert ^a   Velculescu, Victor E ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; GROWTH FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL1;

ANIMAL MODEL; APOPTOSIS; ARTICLE; ATTENUATION; BIOCHEMISTRY; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CELL MUTANT; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENE TARGETING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 20444374445     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2005.05.014     Document Type: Article

References (88)

1. D.A. Altomare, K. Guo, J.Q. Cheng, G. Sonoda, K. Walsh, and J.R. Testa Cloning, chromosomal localization and expression analysis of the mouse Akt2 oncogene Oncogene 11 1995 1055 1060
2. M. Aoki, H. Jiang, and P.K. Vogt Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins Proc. Natl. Acad. Sci. USA 101 2004 13613 13617
3. M. Aoki, C. Schetter, M. Himly, O. Batista, H.W. Chang, and P.K. Vogt The catalytic subunit of phosphoinositide 3-kinase: Requirements for oncogenicity J. Biol. Chem. 275 2000 6267 6275
4. K.E. Bachman, P. Argani, Y. Samuels, N. Silliman, J. Ptak, S. Szabo, H. Konishi, B. Karakas, B.G. Blair, and C. Lin The PIK3CA gene is mutated with high frequency in human breast cancers Cancer Biol. Ther. 3 2004 772 775
5. F.G. Barr, N. Galili, J. Holick, J.A. Biegel, G. Rovera, and B.S. Emanuel Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma Nat. Genet. 3 1993 113 117
6. A. Bellacosa, D. de Feo, A.K. Godwin, D.W. Bell, J.Q. Cheng, D.A. Altomare, M. Wan, L. Dubeau, G. Scambia, and V. Masciullo Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas Int. J. Cancer 64 1995 280 285
7. L. Bi, I. Okabe, D.J. Bernard, A. Wynshaw-Boris, and R.L. Nussbaum Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110alpha subunit of phosphoinositide 3-kinase J. Biol. Chem. 274 1999 10963 10968
8. W.H. Biggs 3rd, J. Meisenhelder, T. Hunter, W.K. Cavenee, and K.C. Arden Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1 Proc. Natl. Acad. Sci. USA 96 1999 7421 7426
9. J.L. Bos, E.R. Fearon, S.R. Hamilton, M. Verlaan-de Vries, J.H. van Boom, A.J. van der Eb, and B. Vogelstein Prevalence of ras gene mutations in human colorectal cancers Nature 327 1987 293 297
10. D.K. Broderick, C. Di, T.J. Parrett, Y.R. Samuels, J.M. Cummins, R.E. McLendon, D.W. Fults, V.E. Velculescu, D.D. Bigner, and H. Yan Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas Cancer Res. 64 2004 5048 5050
11. A. Brunet, A. Bonni, M.J. Zigmond, M.Z. Lin, P. Juo, L.S. Hu, M.J. Anderson, K.C. Arden, J. Blenis, and M.E. Greenberg Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor Cell 96 1999 857 868
12. C.M. Cahill, G. Tzivion, N. Nasrin, S. Ogg, J. Dore, G. Ruvkun, and M. Alexander-Bridges Phosphatidylinositol 3-kinase signaling inhibits DAF-16 DNA binding and function via 14-3-3-dependent and 14-3-3-independent pathways J. Biol. Chem. 276 2001 13402 13410
13. I.G. Campbell, S.E. Russell, D.Y. Choong, K.G. Montgomery, M.L. Ciavarella, C.S. Hooi, B.E. Cristiano, R.B. Pearson, and W.A. Phillips Mutation of the PIK3CA gene in ovarian and breast cancer Cancer Res. 64 2004 7678 7681
14. L.C. Cantley The phosphoinositide 3-kinase pathway Science 296 2002 1655 1657
15. M.H. Cardone, N. Roy, H.R. Stennicke, G.S. Salvesen, T.F. Franke, E. Stanbridge, S. Frisch, and J.C. Reed Regulation of cell death protease caspase-9 by phosphorylation Science 282 1998 1318 1321
16. H.W. Chang, M. Aoki, D. Fruman, K.R. Auger, A. Bellacosa, P.N. Tsichlis, L.C. Cantley, T.M. Roberts, and P.K. Vogt Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase Science 276 1997 1848 1850
17. M. Chee, R. Yang, E. Hubbell, A. Berno, X.C. Huang, D. Stern, J. Winkler, D.J. Lockhart, M.S. Morris, and S.P. Fodor Accessing genetic information with high-density DNA arrays Science 274 1996 610 614
18. W.S. Chen, P.Z. Xu, K. Gottlob, M.L. Chen, K. Sokol, T. Shiyanova, I. Roninson, W. Weng, R. Suzuki, and K. Tobe Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene Genes Dev. 15 2001 2203 2208
19. J.Q. Cheng, A.K. Godwin, A. Bellacosa, T. Taguchi, T.F. Franke, T.C. Hamilton, P.N. Tsichlis, and J.R. Testa AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas Proc. Natl. Acad. Sci. USA 89 1992 9267 9271
20. J.Q. Cheng, B. Ruggeri, W.M. Klein, G. Sonoda, D.A. Altomare, D.K. Watson, and J.R. Testa Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA Proc. Natl. Acad. Sci. USA 93 1996 3636 3641
21. D.A. Cross, D.R. Alessi, P. Cohen, M. Andjelkovich, and B.A. Hemmings Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B Nature 378 1995 785 789
22. J.M. Cummins, M. Kohli, C. Rago, K.W. Kinzler, B. Vogelstein, and F. Bunz X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cells Cancer Res. 64 2004 3006 3008
23. J.M. Cummins, C. Rago, M. Kohli, K.W. Kinzler, C. Lengauer, and B. Vogelstein Tumour suppression: Disruption of HAUSP gene stabilizes p53 Nature 428 2004 486
24. S.R. Datta, H. Dudek, X. Tao, S. Masters, H. Fu, Y. Gotoh, and M.E. Greenberg Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery Cell 91 1997 231 241
25. H. Davies, G.R. Bignell, C. Cox, P. Stephens, S. Edkins, S. Clegg, J. Teague, H. Woffendin, M.J. Garnett, and W. Bottomley Mutations of the BRAF gene in human cancer Nature 417 2002 949 954
26. S.P. Davies, H. Reddy, M. Caivano, and P. Cohen Specificity and mechanism of action of some commonly used protein kinase inhibitors Biochem. J. 351 2000 95 105
27. L. del Peso, M. Gonzalez-Garcia, C. Page, R. Herrera, and G. Nunez Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt Science 278 1997 687 689
28. A. Di Cristofano, B. Pesce, C. Cordon-Cardo, and P.P. Pandolfi Pten is essential for embryonic development and tumour suppression Nat. Genet. 19 1998 348 355
29. J.A. Diehl, M. Cheng, M.F. Roussel, and C.J. Sherr Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization Genes Dev. 12 1998 3499 3511
30. G. Dufour, M.J. Demers, D. Gagne, A.B. Dydensborg, I.C. Teller, V. Bouchard, I. Degongre, J.F. Beaulieu, J.Q. Cheng, and N. Fujita Human intestinal epithelial cell survival and anoikis. Differentiation state-distinct regulation and roles of protein kinase B/Akt isoforms J. Biol. Chem. 279 2004 44113 44122
31. D.A. Fruman, R.E. Meyers, and L.C. Cantley Phosphoinositide kinases Annu. Rev. Biochem. 67 1998 481 507
32. N. Galili, R.J. Davis, W.J. Fredericks, S. Mukhopadhyay, F.J. Rauscher 3rd, B.S. Emanuel, G. Rovera, and F.G. Barr Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma Nat. Genet. 5 1993 230 235
33. S. Guo, G. Rena, S. Cichy, X. He, P. Cohen, and T. Unterman Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence J. Biol. Chem. 274 1999 17184 17192
34. T.E. Harris, and J.C. Lawrence Jr. TOR signaling Sci. STKE 2003 2003 re15
35. R. Hirata, J. Chamberlain, R. Dong, and D.W. Russell Targeted transgene insertion into human chromosomes by adeno-associated virus vectors Nat. Biotechnol. 20 2002 735 738
36. L. Hu, C. Zaloudek, G.B. Mills, J. Gray, and R.B. Jaffe In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002) Clin. Cancer Res. 6 2000 880 886
37. W.G. Kaelin Jr. Choosing anticancer drug targets in the postgenomic era J. Clin. Invest. 104 1999 1503 1506
38. S. Kang, A.G. Bader, and P.K. Vogt Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic Proc. Natl. Acad. Sci. USA 102 2005 802 807
39. R. Katso, K. Okkenhaug, K. Ahmadi, S. White, J. Timms, and M.D. Waterfield Cellular function of phosphoinositide 3-kinases: Implications for development, homeostasis, and cancer Annu. Rev. Cell Dev. Biol. 17 2001 615 675
40. D. Kim, S. Kim, H. Koh, S.O. Yoon, A.S. Chung, K.S. Cho, and J. Chung Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production FASEB J. 15 2001 1953 1962
41. D.H. Kim, M.A. Behlke, S.D. Rose, M.S. Chang, S. Choi, and J.J. Rossi Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy Nat. Biotechnol. 23 2005 222 226
42. M. Kohli, C. Rago, C. Lengauer, K.W. Kinzler, and B. Vogelstein Facile methods for generating human somatic cell gene knockouts using recombinant adeno-associated viruses Nucleic Acids Res. 32 2004 e3
43. G.J. Kops, N.D. de Ruiter, A.M. De Vries-Smits, D.R. Powell, J.L. Bos, and B.M. Burgering Direct control of the Forkhead transcription factor AFX by protein kinase B Nature 398 1999 630 634
44. M.A. Lawlor, and P. Rotwein Insulin-like growth factor-mediated muscle cell survival: Central roles for Akt and cyclin-dependent kinase inhibitor p21 Mol. Cell. Biol. 20 2000 8983 8995
45. J. Li, C. Yen, D. Liaw, K. Podsypanina, S. Bose, S.I. Wang, J. Puc, C. Miliaresis, L. Rodgers, and R. McCombie PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer Science 275 1997 1943 1947
46. K. Lin, J.B. Dorman, A. Rodan, and C. Kenyon daf-16: An HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans Science 278 1997 1319 1322
47. Y. Lu, H. Wang, and G.B. Mills Targeting PI3K-AKT pathway for cancer therapy Rev. Clin. Exp. Hematol. 7 2003 205 228
48. J. Luo, B.D. Manning, and L.C. Cantley Targeting the PI3K-Akt pathway in human cancer: Rationale and promise Cancer Cell 4 2003 257 262
49. N. Majewski, V. Nogueira, P. Bhaskar, P.E. Coy, J.E. Skeen, K. Gottlob, N.S. Chandel, C.B. Thompson, R.B. Robey, and N. Hay Hexokinase-mitochondria interaction mediated by akt is required to inhibit apoptosis in the presence or absence of bax and bak Mol. Cell 16 2004 819 830
50. B.D. Manning, A.R. Tee, M.N. Logsdon, J. Blenis, and L.C. Cantley Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway Mol. Cell 10 2002 151 162
51. L.D. Mayo, and D.B. Donner A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus Proc. Natl. Acad. Sci. USA 98 2001 11598 11603
52. V. Modur, R. Nagarajan, B.M. Evers, and J. Milbrandt FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer J. Biol. Chem. 277 2002 47928 47937
53. N. Nakamura, S. Ramaswamy, F. Vazquez, S. Signoretti, M. Loda, and W.R. Sellers Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN Mol. Cell. Biol. 20 2000 8969 8982
54. K. Nakatani, H. Sakaue, D.A. Thompson, R.J. Weigel, and R.A. Roth Identification of a human Akt3 (protein kinase B gamma) which contains the regulatory serine phosphorylation site Biochem. Biophys. Res. Commun. 257 1999 906 910
55. B.T. Nave, M. Ouwens, D.J. Withers, D.R. Alessi, and P.R. Shepherd Mammalian target of rapamycin is a direct target for protein kinase B: Identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation Biochem. J. 344 1999 427 431
56. M.S. Neshat, I.K. Mellinghoff, C. Tran, B. Stiles, G. Thomas, R. Petersen, P. Frost, J.J. Gibbons, H. Wu, and C.L. Sawyers Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR Proc. Natl. Acad. Sci. USA 98 2001 10314 10319
57. S. Ogg, S. Paradis, S. Gottlieb, G.I. Patterson, L. Lee, H.A. Tissenbaum, and G. Ruvkun The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans Nature 389 1997 994 999
58. B.K. Park, X. Zeng, and R.I. Glazer Akt1 induces extracellular matrix invasion and matrix metalloproteinase-2 activity in mouse mammary epithelial cells Cancer Res. 61 2001 7647 7653
59. K. Podsypanina, L.H. Ellenson, A. Nemes, J. Gu, M. Tamura, K.M. Yamada, C. Cordon-Cardo, G. Catoretti, P.E. Fisher, and R. Parsons Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems Proc. Natl. Acad. Sci. USA 96 1999 1563 1568
60. H. Rajagopalan, A. Bardelli, C. Lengauer, K.W. Kinzler, B. Vogelstein, and V.E. Velculescu Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status Nature 418 2002 934
61. G. Rena, S. Guo, S.C. Cichy, T.G. Unterman, and P. Cohen Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B J. Biol. Chem. 274 1999 17179 17183
62. S. Rokudai, N. Fujita, O. Kitahara, Y. Nakamura, and T. Tsuruo Involvement of FKHR-dependent TRADD expression in chemotherapeutic drug-induced apoptosis Mol. Cell. Biol. 22 2002 8695 8708
63. J.A. Romashkova, and S.S. Makarov NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling Nature 401 1999 86 90
64. L. Rossig, A.S. Jadidi, C. Urbich, C. Badorff, A.M. Zeiher, and S. Dimmeler Akt-dependent phosphorylation of p21(Cip1) regulates PCNA binding and proliferation of endothelial cells Mol. Cell. Biol. 21 2001 5644 5657
65. S. Saha, A.B. Sparks, C. Rago, V. Akmaev, C.J. Wang, B. Vogelstein, K.W. Kinzler, and V.E. Velculescu Using the transcriptome to annotate the genome Nat. Biotechnol. 20 2002 508 512
66. Y. Samuels, Z. Wang, A. Bardelli, N. Silliman, J. Ptak, S. Szabo, H. Yan, A. Gazdar, S.M. Powell, and G.J. Riggins High frequency of mutations of the PIK3CA gene in human cancers Science 304 2004 554
67. I. Sansal, and W.R. Sellers The biology and clinical relevance of the PTEN tumor suppressor pathway J. Clin. Oncol. 22 2004 2954 2963
68. M. Schena, D. Shalon, R.W. Davis, and P.O. Brown Quantitative monitoring of gene expression patterns with a complementary DNA microarray Science 270 1995 467 470
69. L. Shayesteh, Y. Lu, W.L. Kuo, R. Baldocchi, T. Godfrey, C. Collins, D. Pinkel, B. Powell, G.B. Mills, and J.W. Gray PIK3CA is implicated as an oncogene in ovarian cancer Nat. Genet. 21 1999 99 102
70. S. Shirasawa, M. Furuse, N. Yokoyama, and T. Sasazuki Altered growth of human colon cancer cell lines disrupted at activated Ki-ras Science 260 1993 85 88
71. M.J. Smyth, K. Takeda, Y. Hayakawa, J.J. Peschon, M.R. van den Brink, and H. Yagita Nature's TRAIL-on a path to cancer immunotherapy Immunity 18 2003 1 6
72. P.A. Steck, M.A. Pershouse, S.A. Jasser, W.K. Yung, H. Lin, A.H. Ligon, L.A. Langford, M.L. Baumgard, T. Hattier, and T. Davis Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers Nat. Genet. 15 1997 356 362
73. B. Stiles, V. Gilman, N. Khanzenzon, R. Lesche, A. Li, R. Qiao, X. Liu, and H. Wu Essential role of AKT-1/protein kinase B alpha in PTEN-controlled tumorigenesis Mol. Cell. Biol. 22 2002 3842 3851
74. A. Suzuki, J.L. de la Pompa, V. Stambolic, A.J. Elia, T. Sasaki, I. del Barco Barrantes, A. Ho, A. Wakeham, A. Itie, and W. Khoo High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice Curr. Biol. 8 1998 1169 1178
75. A. Suzuki, J. Lu, G. Kusakai, A. Kishimoto, T. Ogura, and H. Esumi ARK5 is a tumor invasion-associated factor downstream of Akt signaling Mol. Cell. Biol. 24 2004 3526 3535
76. M. Tamura, J. Gu, K. Matsumoto, S. Aota, R. Parsons, and K.M. Yamada Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN Science 280 1998 1614 1617
77. M. Tamura, J. Gu, T. Takino, and K.M. Yamada Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: Differential involvement of focal adhesion kinase and p130Cas Cancer Res. 59 1999 442 449
78. B. Vanhaesebroeck, and D.R. Alessi The PI3K-PDK1 connection: More than just a road to PKB Biochem. J. 346 2000 561 576
79. B. Vanhaesebroeck, and M.D. Waterfield Signaling by distinct classes of phosphoinositide 3-kinases Exp. Cell Res. 253 1999 239 254
80. V. Vasko, M. Saji, E. Hardy, M. Kruhlak, A. Larin, V. Savchenko, M. Miyakawa, O. Isozaki, H. Murakami, and T. Tsushima Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer J. Med. Genet. 41 2004 161 170
81. V.E. Velculescu, L. Zhang, B. Vogelstein, and K.W. Kinzler Serial analysis of gene expression Science 270 1995 484 487
82. I. Vivanco, and C.L. Sawyers The phosphatidylinositol 3-Kinase AKT pathway in human cancer Nat. Rev. Cancer 2 2002 489 501
83. C.J. Vlahos, W.F. Matter, K.Y. Hui, and R.F. Brown A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4- one (LY294002) J. Biol. Chem. 269 1994 5241 5248
84. T. Waldman, K.W. Kinzler, and B. Vogelstein p21 is necessary for the p53-mediated G(1) arrest in human cancer cells Cancer Res. 55 1995 5187 5190
85. S. Wang, and W.S. El-Deiry TRAIL and apoptosis induction by TNF-family death receptors Oncogene 22 2003 8628 8633
86. S.I. Wang, J. Puc, J. Li, J.N. Bruce, P. Cairns, D. Sidransky, and R. Parsons Somatic mutations of PTEN in glioblastoma multiforme Cancer Res. 57 1997 4183 4186
87. I.B. Weinstein Cancer. Addiction to oncogenes the Achilles heal of cancer Science 297 2002 63 64
88. B.P. Zhou, Y. Liao, W. Xia, Y. Zou, B. Spohn, and M.C. Hung HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation Nat. Cell Biol. 3 2001 973 982